• Publications
  • Influence
Second consensus statement on the diagnosis of multiple system atrophy
TLDR
We propose new diagnostic criteria for multiple system atrophy with predominant parkinsonism and MSA with predominant cerebellar ataxia to designate the predominant motor features. Expand
  • 1,533
  • 136
  • PDF
Consensus statement on the diagnosis of multiple system atrophy
We report the results of a consensus conference on the diagnosis of multiple system atrophy (MSA). We describe the clinical features of the disease, which include four domains: autonomicExpand
  • 1,322
  • 93
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
  • C. Götz, W. Poewe, +9 authors L. Seidl
  • Psychology, Medicine
  • Movement disorders : official journal of the…
  • 1 September 2004
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilizationExpand
  • 1,127
  • 68
  • PDF
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features andExpand
  • 898
  • 34
  • PDF
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
We aimed to develop and validate a novel rating scale for multiple system atrophy (Unified Multiple System Atrophy Rating Scale ‐ UMSARS). The scale comprises the following components: Part I,Expand
  • 339
  • 28
  • PDF
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
Alpha‐synucleinopathies (ASP) are neurodegenerative disorders, characterized by accumulation of misfolded α‐synuclein, selective neuronal loss, and extensive gliosis. It is accepted that microgliosisExpand
  • 344
  • 28
Multiple system atrophy: A review of 203 pathologically proven cases
We report the clinicopathological features of 203 cases of pathologically proven multiple system atrophy (MSA) from 108 publications up to February 1995. The majority of patients showed symptoms inExpand
  • 670
  • 25
The natural history of multiple system atrophy: a prospective European cohort study
Summary Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative movement disorder that is characterised by autonomic failure, cerebellar ataxia, and parkinsonismExpand
  • 282
  • 19
  • PDF
Multiple system atrophy: an update
Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder that presents with autonomic failure in combination with parkinsonism or cerebellar ataxia. Over theExpand
  • 300
  • 18
  • PDF